Treatment of Neovascular Age-Related Macular Degeneration with Anti-VEGF Agents: Predictive Factors of Long-Term Visual Outcomes

Table 1

Baseline characteristics of the patients.

Number of patients	117
Women, n (%)	68 (58.1)
Mean age at diagnosis ± SD, years	75.70 ± 7.03
Age at diagnosis (range), years	54–89
Mean BCVA ± SD, ETDRS letters	47 ± 19.6
CNV lesion subtype, n (%)
Occult	55 (47.0)
Minimally classic	35 (29.9)
Predominantly classic	16 (13.7)
Retinal angiomatous proliferation	8 (6.8)
Not classified	3 (2.6)
Mean CFT ± SD, μm	311.37 ± 140.85
Subfoveal hemorrhage, n (%)	10 (8.5)
Subretinal fibrosis, n (%)	9 (7.7)

SD: standard deviation; ETDRS: early treatment diabetic retinopathy study; BCVA: best-corrected visual acuity; CNV: choroidal neovascularization; CFT: central foveal thickness.